.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKesson
Colorcon
Healthtrust
Cantor Fitzgerald
Citi
McKinsey
Mallinckrodt
Chinese Patent Office
Boehringer Ingelheim

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021559

« Back to Dashboard
NDA 021559 describes INFUVITE ADULT, which is a drug marketed by Sandoz Inc and is included in two NDAs. It is available from one supplier. Additional details are available on the INFUVITE ADULT profile page.

The generic ingredient in INFUVITE ADULT is alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k profile page.

Summary for 021559

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A PALMITATE','VITAMIN K') AND hsdb_dru' at line 1
Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0